Join

Enter Details

Comment on stories, receive email newsletters & alerts.

@
This is your permanent identity for Gizmodo, Kotaku, Lifehacker and Business Insider Australia
Your email must be valid for account activation
Minimum of 8 standard keyboard characters

Subscribe

Great discounts, competitions and special offers from our partners.
Email newsletters aren't ready to go out just yet, but will contain a brief summary of our top stories, news alerts, plus details of competitions and reader events.
Having issues creating your account? Contact Support

Forgotten Password

Enter Details


Back to log in

Legendary Short-Seller Jim Chanos Explains Why He Would Never Invest In Herbalife

Legendary short-seller Jim Chanos, the founder of Kynikos Associates, told Bloomberg TV’s Trish Regan that he wouldn’t invest in Herbalife. 

Chanos, who said he doesn’t “have a dog in the Herbalife hunt”, is a big sceptic of the multi-level marketing model.

“I think any business that’s dependent ultimately on pulling the wool over your customers whether its the distributors who take on more product than they can sell or the customers who are being sold product at two to three times than what’s available down the street I think is a unstable long term business model that I wouldn’t want to invest in. Whether you want to short it or not is another issue,” he said.

“When you’re in the business, in effect, of fooling your customers and your salesforce you don’t have a really sustainable business.” 

Herbalife is a multi-level marketing firm that sells nutrition products. It has become one of the most controversial stocks in the market because it’s in the middle of a huge hedge fund war. 

On the bearish side, hedge fund manager Bill Ackman, the CEO of Pershing Square, is shorting more than 20 million shares with a price target of zero because he believes the company is a “pyramid scheme”.

On the long side, there’s hedge fund hot-shot Daniel Loeb, the founder of Third Point LLC who disclosed an 8.24% stake, and Ackman’s long-time rival Carl Icahn, who has a 12.98% stake.

Watch the Chanos’ interview in the video below:
 

Now Watch: How Herbalife Became A Battleground Stock For Two Wall Street Heavyweights

 

Please enable Javascript to watch this video

Follow Business Insider Australia on Facebook, Twitter, and LinkedIn